Literature DB >> 16365764

[Check-up-examinations in internal medicine].

S Hunziker1, P Hengstler, L Zimmerli, M Battegay, E Battegay.   

Abstract

A growing body of evidence supports or rejects preventive interventions in asymptomatic adults. Thus, counseling for smoking cessation and some immunizations have been shown to be cost-effective. Evidence supports screening for body weight (obesity), hypertension, hyperlipidemia, cervical cancer, colorectal cancer and breast cancer. Screening for lung, pancreatic and ovarian cancer has no effect on outcome and should not be performed. Controversial preventive interventions include general screening for diabetes mellitus in the young adult, thyroid disorders and prostate cancer. Physicians should be aware of a possible hidden agenda in patients presenting for a check-up.

Entities:  

Mesh:

Year:  2006        PMID: 16365764     DOI: 10.1007/s00108-005-1536-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

1.  Screening adults for lipid disorders: recommendations and rationale.

Authors: 
Journal:  Am J Prev Med       Date:  2001-04       Impact factor: 5.043

2.  The best screening test for colorectal cancer--a personal choice.

Authors:  S H Woolf
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  [Potentials of and approaches to prevention. Current developments in Germany].

Authors:  R Apitz; S F Winter
Journal:  Internist (Berl)       Date:  2004-02       Impact factor: 0.743

5.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

Authors:  Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Barry A Turnbull; Michael E Ross
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

6.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE EVALUATION AND TREATMENT OF HYPERTHYROIDISM AND HYPOTHYROIDISM.

Authors:  H Jack Baskin; Rhoda H Cobin; Daniel S Duick; Hossein Gharib; Richard B Guttler; Michael M Kaplan; Robert L Segal; Jeffrey R Garber; Carlos R Hamilton; Yehuda Handelsman; Richard Hellman; John S Kukora; Philip Levy; Pasquale J Palumbo; Steven M Petak; Herbert I Rettinger; Helena W Rodbard; F John Service; Talla P Shankar; Sheldon S Stoffer; John B Tourtelot
Journal:  Endocr Pract       Date:  2002-11       Impact factor: 3.443

7.  14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.

Authors:  F E Alexander; T J Anderson; H K Brown; A P Forrest; W Hepburn; A E Kirkpatrick; B B Muir; R J Prescott; A Smith
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

8.  The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma.

Authors:  G Johannesson; G Geirsson; N Day
Journal:  Int J Cancer       Date:  1978-04-15       Impact factor: 7.396

Review 9.  Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Steven Teutsch; Mark Johnson
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.